An improved algorithm of white matter hyperintensity detection in elderly adults

por Ding, T, Cohen, AD, O’Connor, EE, Karim, HT, Crainiceanu, A, Muschelli, J, Lopez, O, Klunk, WE, Aizenstein, HJ, Krafty, R, Crainiceanu, CM, Tudorascu, DL
Publicado 2019

Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline

por Tudorascu, DL, Laymon, CM, Zammit, M, Minhas, DS, Anderson, SJ, Ellison, PA, Zaman, S, Ances, BM, Sabbagh, M, Johnson, SC, Mathis, CA, Klunk, WE, Handen, BL, Christian, BT, Cohen, AD
Publicado 2020

Reduced binding of Pittsburgh Compound-B in areas of white matter hyperintensities

por Goodheart, A.E., Tamburo, E., Minhas, D., Aizenstein, H.J., McDade, E., Snitz, B.E., Price, J.C., Mathis, C.A., Lopez, O.L., Klunk, W.E., Cohen, A.D.
Publicado 2015

BL-7010 Demonstrates Specific Binding to Gliadin and Reduces Gluten-Associated Pathology in a Chronic Mouse Model of Gliadin Sensitivity

por McCarville, Justin L., Nisemblat, Yotam, Galipeau, Heather J., Jury, Jennifer, Tabakman, Rinat, Cohen, Ad, Naftali, Esmira, Neiman, Bela, Halbfinger, Efrat, Murray, Joseph A., Anbazhagan, Arivarasu N., Dudeja, Pradeep K., Varvak, Alexander, Leroux, Jean-Christophe, Verdu, Elena F.
Publicado 2014

P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESS...

por Einsele, H, Cohen, AD, Delforge, M, Hillengass, J, Goldschmidt, H, Weisel, K, Raab, M-S, Scheid, C, Schecter, JM, De Braganca, KC, Varsos, H, Yeh, T-M, Wang, L, Vogel, M, Corsale, C, Akram, M, Pacaud, L, Nesheiwat, T, Agha, M, Cohen, YC
Publicado 2022

B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND E...

por van de Donk, NWCJ, Delforge, M, Agha, M, Cohen, AD, Cohen, YC, Hillengass, J, Anguille, S, Kerre, T, Roeloffzen, W, Schecter, JM, De Braganca, KC, Varsos, H, Wang, L, Vogel, M, Zudaire, E, Corsale, C, Akram, M, Geng, D, Nesheiwat, T, Pacaud, L, Sonneveld, P, Zweegman, S
Publicado 2022

B09 CARTITUDE-2 COHORT B 18-MONTH FOLLOW-UP: CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND EARLY RELAPSE AFT...

por Zweegman, S., Agha, M., Cohen, A.D., Cohen, Y.C., Anguille, S., Kerre, T., Roeloffzen, W., Madduri, D., Schecter, J.M., De Braganca, K.C., Jackson, C.C., Varsos, H., Mistry, P., Roccia, T., Xu, X., Li, K., Zudaire, E., Corsale, C., Akram, M., Geng, D., Pacaud, L., Sonneveld, P., van de Donk, N.
Publicado 2023

P28 EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER EXPOSURE TO NON-CELLULAR ANTI-B-CELL MATURATION ANTIGEN (B...

por van de Donk, N., Mateos, M.-V., Cohen, Y.C., Rodriguez-Otero, P., Paiva, B., Cohen, A.D., Martin, T., Suvannasankha, A., Madduri, D., Corsale, C., Schecter, J.M., De Braganca, K.C., Jackson, C.C., Varsos, H., Deraedt, W., Roccia, T., Mistry, P., Xu, X., Li, K., Zudaire, E., Akram, M., Pacaud, L., Avivi, I., San-Miguel, J.
Publicado 2023